RT Journal Article
SR Electronic
T1 An emerging role of microplastics in the etiology of lung ground glass nodules
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.04.22.21255586
DO 10.1101/2021.04.22.21255586
A1 Qiqing Chen
A1 Jiani Gao
A1 Hairui Yu
A1 Hang Su
A1 Yan Yang
A1 Yajuan Cao
A1 Qun Zhang
A1 Yijiu Ren
A1 Huahong Shi
A1 Chang Chen
A1 Haipeng Liu
YR 2021
UL http://medrxiv.org/content/early/2021/04/25/2021.04.22.21255586.abstract
AB Pulmonary ground glass nodules (GGNs) have been increasingly identified in past decades and is becoming an important clinical dilemma in oncology. Meanwhile, humans persistently inhale microplastics which are dominant in the air. However, the retention of “non-self” microplastics in human lung and its correlation with pulmonary GGNs remains elusive. In this study, we firstly demonstrated the presence of microfibers and microplastics in human lung, with higher detection rates in GGNs in comparison to those in normal tissue. Moreover, both types and colors of microfibers in tumor were richer than those in normal tissues. Intriguingly, high risk of microfibers exposure predisposes the formation of pulmonary GGN. Further, increased roughness surface was observed in microfibers isolated in human lung, indicating the possible link of surface roughness to the formation of pulmonary GGN. Collectively, our findings reveal an emerging role of environmental microplastics exposure in the etiology of pulmonary GGN.One Sentence Summary The exposure of environmental microplastics is a risk factor of pulmonary GGN.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project was supported by grants from the National Natural Science Foundation of China (81922030, 42077371 and 81770006 to H.L. and Q.C.).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was conducted in accordance with the principles of the Declaration of Helsinki. The study protocol was approved by the ethics committee of the Shanghai Pulmonary Hospital (IRB NO. K21-020), and informed consent from individual patients was waived for this retrospective analysis.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used during the study appear in the submitted article.